top of page

INTRODUCING QRX-3 

QRX-3, developed by NeuKidney, is a pioneering treatment targeting Chronic Kidney Disease (CKD). This novel drug therapy addresses the substantial global CKD burden, aiming to improve patient outcomes. It demonstrates promising results in clinical trials, potentially slowing disease progression and enhancing kidney function, thus potentially reducing reliance on dialysis and transplants. QRX-3 represents an innovative approach in CKD management, with significant implications for the healthcare market.

Contact

P.O Box 1517 Arcola, Texas 77545

​

info@neukidney.com

Be in the Know

Stay up to date with our product road map, research and development.

Thanks for submitting!

© 2023 by Neukidney Inc.

Powered by WITS Healthcare Consulting

bottom of page